Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia
✍ Scribed by Stilgenbauer, S; Bullinger, L; Benner, A; Wildenberger, K; Bentz, M; Döhner, K; Ho, AD; Lichter, P; Döhner, H
- Book ID
- 110054287
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 72 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Approximately 10% of B-cell chronic lymphocytic leukemia (B-CLL) cases have structural chromosomal aberrations involving band 13q14. To evaluate a possible role of RBI gene deletions in B-CLL we investigated the malignant cells of 27 patients by molecular genetic and cytogenetic techniques. Four of
Soluble CD83 (sCD83), a potent immunosuppressive agent, circulates at elevated levels in some chronic lymphocytic leukemia (CLL) patients. We report that CLL patients with elevated plasma sCD83 levels had significantly shorter (P=0.038) treatment free survival. Culture of CLL cells with solid phase
## Abstract Deletion at 13q14 is detected by fluorescence in situ hybridization (FISH) in about 50% of chronic lymphocytic leukemia (CLL). Although CLL with 13q deletion as the sole cytogenetic abnormality (del13q‐only) usually have good prognosis, more aggressive clinical courses are documented fo
Chronic lymphocytic leukemia (CLL) is the most common adult form of leukemia in the Western world, however, infrequent in the Eastern. It shows a remarkable heterogeneity, with some patients having an almost normal lifespan, others surviving only several years after diagnosis despite intensive thera